A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache
Completed · Phase 2
Conditions studied: Migraine Headache
In brief
The purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache.
Key facts
- Study ID
- NCT00055484
- Run by
- Elan Pharmaceuticals
- People needed
- 204
- Starts
- 2002-03-01
- Expected to finish
- 2003-05-01
- Last updated by the study team
- 2015-12-14
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Medical Affiliated Research Center — Huntsville, Alabama, United States
- University of South Alabama Medical Ctr Department of Neurology — Mobile, Alabama, United States
- Valley Neurological Headache Clinic — Phoenix, Arizona, United States
- The New England Center for Headache — Stamford, Connecticut, United States
- Radiant Research — Overland Park, Kansas, United States
- Michigan Head-Pain & Neurological Institute — Ann Arbor, Michigan, United States
- Mercy Health Research — Chesterfield, Missouri, United States
- Headache Care Center — Springfield, Missouri, United States
- Neurological Associates of Tulsa — Tulsa, Oklahoma, United States
- Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States
- MetaClin Research — Austin, Texas, United States
- Houston Headache Clinic — Houston, Texas, United States
- Radiant Research — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.